A UCLA-led study suggests that women who are 65 years old or older with high-risk breast cancer and are treated with chemotherapy are more likely to develop a substantial decline in physical function.
Globally, 2.3 million women are diagnosed with breast cancer every year, according to the World Health Organization. Advances in treating breast cancer are improving care and quality of life.
For patients with breast cancer, there are racial and ethnic differences in treatment declination, according to a study published online May 9 in JAMA Network Open.
Dancer and choreographer Beaux Harris was diagnosed with a genetic mutation two years ago, which gives her a 90% chance of developing breast cancer and a 60% chance of ovarian cancer
According to Falyn Katz, CEO of Melanoma Canada, "one in three cancers diagnosed is skin cancer. It's actually more common than breast, prostate, lung and colon combined."
Poster session details are as follows: Date: Thursday, May 16, 2024 Time: 12:00 – 1:00 p.m. CET/ 6:00 – 7:00 a.m. ET Category: Metastatic Breast Cancer
The reminders are everywhere. When a woman turns 40, doctors say she should begin receiving yearly mammograms to detect breast cancer. You see it on posters, ads and buttons.
The Canadian Cancer Society (CCS) is urging all provinces and territories to begin breast cancer screening at age 40 for those at average risk of the disease.
Researchers at The Institute of Cancer Research, London, have increased our understanding of how a cancer drug called a PARP inhibitor stops working in women with breast cancer that has spread. This research could ultimately help predict…
When you think about obesity, you may not connect it to cancer. However, researchers long have suspected a link between certain cancers and weight. Among those are endometrial, ovarian, colon, liver, pancreatic and postmenopausal breast…
Enveric Biosciences (NASDAQ:ENVB), a Nasdaq-listed psychedelics biotech firm, has entered into a non-binding term sheet with an undisclosed biotech company (licensee) for an exclusive license to two patented methods aimed at treating…
SAN FRANCISCO, May 08, 2024 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (("Olema" or "Olema Oncology, NASDAQ:OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted…
Researchers used a breast cancer cell line panel and primary tumor explants from breast and cervical cancer patients to examine two different cellular contractility modes: one that generates collective tissue surface tension that keeps…